TAK-228
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for TAK-228, covering 2018-11-19 to 2024-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors [Phase 1]